TELMISARTAN ALEM telmisartan 40mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan alem telmisartan 40mg tablet blister pack

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan alem is indicated for:,? treatment of hypertension in adults,? prevention of cardiovascular morbidity and mortality in adults 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see section 5.1 pharmacodynamic properties, clinical trials)

TELMISARTAN APPL telmisartan 40mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan appl telmisartan 40mg tablet blister pack

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan appl is indicated for:- treatment of hypertension, - prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

TELMISARTAN APA telmisartan 40mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan apa telmisartan 40mg tablet blister pack

alembic pharmaceuticals australia pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium stearylfumarate; povidone; mannitol; sodium hydroxide; magnesium stearate; meglumine - telmisartan apa is indicated for:- treatment of hypertension, - prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Telmisartan/Amlodipine GENPAR 40/10 telmisartan/amlodipine (as besilate) 40/10 mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan/amlodipine genpar 40/10 telmisartan/amlodipine (as besilate) 40/10 mg tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg; telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; meglumine; povidone; magnesium stearate; citric acid; mannitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Telmisartan/Amlodipine GENPAR 40/5 telmisartan/amlodipine (as besilate) 40/5 mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan/amlodipine genpar 40/5 telmisartan/amlodipine (as besilate) 40/5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.935 mg; telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; meglumine; povidone; magnesium stearate; citric acid; mannitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

TELMISARTAN RAN telmisartan 40mg  tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan ran telmisartan 40mg tablet blister pack

sun pharma anz pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; magnesium stearate; meglumine; sorbitol; povidone - the proposed indications are identical to those for the approved innovator product; based on the latest published micardis pi (most recent amendment jan11) the indications are (i) treatment of hypertension, and (ii) prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

TELMISARTAN RANBAXY telmisartan 40mg  tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan ranbaxy telmisartan 40mg tablet blister pack

sun pharma anz pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; magnesium stearate; meglumine; sorbitol; povidone - the proposed indications are identical to those for the approved innovator product; based on the latest published micardis pi (most recent amendment jan11) the indications are (i) treatment of hypertension, and (ii) prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

TELMISARTAN HCT GH 80/12.5mg telmisartan 80mg and hydrochlorothiazide 12.5mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan hct gh 80/12.5mg telmisartan 80mg and hydrochlorothiazide 12.5mg tablet blister pack

generic health pty ltd - telmisartan, quantity: 80 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: povidone; mannitol; purified water; meglumine; sodium hydroxide; lactose monohydrate; sodium stearylfumarate; magnesium stearate; iron oxide red - telmisartan hct gh is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

TELMISARTAN HCT MYLAN 40/12.5 MG telmisartan 40mg/hydrochlorothiazide 12.5mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan hct mylan 40/12.5 mg telmisartan 40mg/hydrochlorothiazide 12.5mg tablet blister pack

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; telmisartan, quantity: 40 mg - tablet, multilayer - excipient ingredients: sodium starch glycollate type a; meglumine; lactose monohydrate; sodium hydroxide; maize starch; microcrystalline cellulose; mannitol; magnesium stearate; povidone; iron oxide red - telmisartan hct mylan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

TELMISARTAN/HCT SANDOZ 80mg/12.5mg telmisartan 80mg / hydrochlorothiazide 12.5mg blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

telmisartan/hct sandoz 80mg/12.5mg telmisartan 80mg / hydrochlorothiazide 12.5mg blister pack

sandoz pty ltd - telmisartan, quantity: 80 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: lactose; povidone; citric acid monohydrate; sodium hydroxide; macrogol poly(vinyl alcohol) grafted polymer; magnesium stearate; meglumine; colloidal anhydrous silica; lactose monohydrate; crospovidone - telmisartan/hct sandoz? is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.